12,212 followers
RT @FrontOncology: New research: Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert rev…
RT @FrontOncology: New research: Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert rev…
New research: Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice: Olaparib, a poly(ADP-ribose) polymerase inhibitor, in combination with the antiangiogenic agent… https://t.co